Picture of Apellis Pharmaceuticals logo

APLS — Apellis Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Apellis Pharmaceuticals Q1 Basic EPS USD -0.54

May 07 (Reuters) - Apellis Pharmaceuticals Q1 operating income USD -62.09
million.
* Q1 operating expenses USD 234.415 million
* Q1 net income USD -66.423 million
* Q1 product revenue USD 163.075 million

Recent news on Apellis Pharmaceuticals

See all news